Dexcom, Inc.

Dexcom, Inc. — FDA 510(k) Submissions

Dexcom, Inc. has submitted 24 FDA 510(k) premarket notifications since 2014, of which 21 received clearance as substantially equivalent to a predicate device.

The company's most frequent device categories include Integrated Continuous Glucose Monitoring System, Factory Calibrated, Integrated Continuous Glucose Monitoring System For Non-intensive Diabetes Management, Continuous Glucose Monitor Informed Insulin Dose Calculator, Continuous Glucose Monitor Retrospective Data Analysis Software, Continuous Glucose Monitor Secondary Display . Use the specialty filter in the sidebar to narrow results.